美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

恩宗药业

0.0600

0.0000

成交量：1.84万

成交额：1,121.72

市值：445.29万

市盈率：-0.80

高：0.0635

开：0.0635

低：0.0600

收：0.0600

52周最高：0.1299

52周最低：0.0150

股本：7,421.46万

流通股本：3,011.40万

量比：0.22

换手率：0.06%

股息：- -

股息率：- -

每股收益(TTM):-0.0746

每股收益(LYR):-0.0067

净资产收益率：-7.79%

总资产收益率：-1.88%

市净率：-1.76

市盈率(LYR):-8.96

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

恩宗药业

交易所：

OTCQB

成立时间：

1981

员工人数：

1

公司地址：

20 Commerce Drive,Suite 135,Cranford,New Jersey,United States

官网：

http://www.enzon.com

邮编：

07016

电话：

传真：

- -

简介：

Enzon Pharmaceuticals, Inc.是一家致力于在病患医疗需求极大的创新疗法研究和开发的生物技术公司。这家公司收取从其他相关公司采用该公司专有的聚乙二醇化定制连接器技术的许用证书使用费。这家公司的使用费收入，也就是佩乐能、Sylatron、Macugen , OMONTYS, Oncaspar 和Adagen.。主要的使用费收入是由莫克公司销售的佩乐能。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ENZN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ENZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","market":"US","secType":"STK","nameCN":"恩宗药业","latestPrice":0.06,"timestamp":1774296000000,"preClose":0.06,"halted":0,"volume":18403,"delay":15,"changeRate":0,"floatShares":30114014,"shares":74214603,"eps":-0.074553,"marketStatus":"未开盘","change":0,"latestTime":"03-23 16:00:00 EDT 延时","open":0.0635,"high":0.0635,"low":0.06,"amount":1121.7215099999999,"amplitude":0.058333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.074553,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.06,"volumeRatio":0.221419},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","floatShares":30114014,"roa":"-1.88%","roe":"-7.79%","lyrEps":-0.006696,"volumeRatio":0.221419,"shares":74214603,"dividePrice":0,"high":0.0635,"amplitude":0.058333,"preClose":0.06,"low":0.06,"week52Low":0.015,"pbRate":"-1.76","week52High":0.1299,"institutionHeld":0,"latestPrice":0.06,"eps":-0.074553,"divideRate":0,"volume":18403,"delay":15,"ttmEps":-0.074553,"open":0.0635,"prevYearClose":0.0379,"prevWeekClose":0.06,"prevMonthClose":0.0601,"prevQuarterClose":0.0379,"fiveDayClose":0.05,"twentyDayClose":0.0668,"sixtyDayClose":0.0421},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-09-30","symbol":"ENZN","amount":0.12,"name":"恩宗药业","recordDate":"2019-10-15","payableDate":"2019-10-01","currency":"USD","type":"dividend","dateTimestamp":1569816000000},{"market":"US","date":"2019-02-20","symbol":"ENZN","amount":0.06,"name":"恩宗药业","recordDate":"2019-03-21","payableDate":"2019-02-21","currency":"USD","type":"dividend","dateTimestamp":1550638800000},{"market":"US","date":"2017-09-29","symbol":"ENZN","amount":0.15,"name":"恩宗药业","recordDate":"2017-09-28","payableDate":"2017-08-30","currency":"USD","type":"dividend","dateTimestamp":1506657600000},{"market":"US","date":"2016-12-30","symbol":"ENZN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1483074000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-11-28","paymentDate":"2016-12-12","value":0.15,"currency":"USD"},{"executeDate":"2017-09-29","recordDate":"2017-08-30","paymentDate":"2017-09-28","value":0.15,"currency":"USD"},{"executeDate":"2019-02-20","recordDate":"2019-02-21","paymentDate":"2019-03-21","value":0.06,"currency":"USD"},{"executeDate":"2019-09-30","recordDate":"2019-10-01","paymentDate":"2019-10-15","value":0.12,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENZN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":269599,"yearFounded":1981,"employeeNum":1,"address":"20 Commerce Drive,Suite 135,Cranford,New Jersey,United States","zipCode":"07016","officePhone":"732 980 4500"},"stockCompanyDetail":{"websiteUrl":"http://www.enzon.com","stockEarnings":[{"period":"1week","weight":0.0926},{"period":"1month","weight":-0.0788},{"period":"3month","weight":-0.0604},{"period":"6month","weight":0.0213},{"period":"1year","weight":-0.0451},{"period":"ytd","weight":-0.0679}],"description":"Enzon Pharmaceuticals, Inc.是一家致力于在病患医疗需求极大的创新疗法研究和开发的生物技术公司。这家公司收取从其他相关公司采用该公司专有的聚乙二醇化定制连接器技术的许用证书使用费。这家公司的使用费收入，也就是佩乐能、Sylatron、Macugen , OMONTYS, Oncaspar 和Adagen.。主要的使用费收入是由莫克公司销售的佩乐能。","exchange":"OTCQB","name":"恩宗药业","nameEN":"Enzon Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":null}}